Myelin-Oligodendrocyte Glycoprotein
"Myelin-Oligodendrocyte Glycoprotein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A transmembrane protein present in the MYELIN SHEATH of the CENTRAL NERVOUS SYSTEM. It is one of the main autoantigens implicated in the pathogenesis of MULTIPLE SCLEROSIS.
| Descriptor ID |
D063308
|
| MeSH Number(s) |
D12.776.395.550.114.500 D12.776.543.550.195.500 D12.776.543.620.550 D12.776.631.580.530 D23.050.422.625
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Myelin-Oligodendrocyte Glycoprotein".
Below are MeSH descriptors whose meaning is more specific than "Myelin-Oligodendrocyte Glycoprotein".
This graph shows the total number of publications written about "Myelin-Oligodendrocyte Glycoprotein" by people in this website by year, and whether "Myelin-Oligodendrocyte Glycoprotein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 3 | 3 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 2 | 2 |
| 2013 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 4 | 4 |
| 2023 | 1 | 3 | 4 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myelin-Oligodendrocyte Glycoprotein" by people in Profiles.
-
Intranasal sensitization model of alopecia areata using pertussis toxin as adjuvant. Front Immunol. 2024; 15:1469424.
-
Frequency, characteristics, predictors and treatment of relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Mult Scler Relat Disord. 2024 Jul; 87:105672.
-
Fulminant Anti-Myelin Oligodendrocyte Glycoprotein-Associated Cerebral Cortical Encephalitis: Case Series of a Severe Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Phenotype. Pediatr Neurol. 2023 10; 147:36-43.
-
GPR43 stimulation on TCRa?+ intraepithelial colonic lymphocytes inhibits the recruitment of encephalitogenic T-cells into the central nervous system and attenuates the development of autoimmunity. J Neuroinflammation. 2023 Jun 01; 20(1):135.
-
Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2. Mult Scler. 2023 04; 29(4-5):576-584.
-
Myelin Oligodendrocyte Glycoprotein Optic Neuritis Mimicking Nonarteritic Anterior Ischemic Optic Neuropathy. J Neuroophthalmol. 2024 Jun 01; 44(2):e222-e223.
-
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis Mimicking Pituitary Apoplexy With Bitemporal Field Loss. J Neuroophthalmol. 2024 Mar 01; 44(1):e73-e75.
-
Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder. Neurology. 2023 02 28; 100(9):e985-e994.
-
MOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls. Ann Neurol. 2023 02; 93(2):271-284.
-
Delayed Diagnosis of Anti-Myelin Oligodendrocyte Glycoprotein One Decade After Presumed Recurrent Acute Disseminated Encephalomyelitis. J Neuroophthalmol. 2022 06 01; 42(2):e469-e472.